Epigenomics · 2016 · 26 citations · 20 references
Life SciencesMolecular BiologyOncologyGene ExpressionGene Regulatory NetworksMolecular OncologyCancer GenomicsCancer TranscriptomicsGastrointestinal Stromal TumorsMicrorna BiologyMicrorna-mediated RegulationMolecular Tumor ProfilingGene Expression Network AnalysisMicroarray AnalysisMicrorna In CancerMicrorna ProfilingMicrorna Regulation In CancerMicrorna Regulatory NetworksTherapeutic Target IdentificationTranscriptional Regulatory Networks
AIM: Currently, little is known about differences in miRNA expression between KIT/PDGFRA mutant and KIT/PDGFRA wild-type (WT)-SDH deficient gastrointestinal stromal tumors (GIST). This prompted us to perform an integrated multiple expression profile of miRNA and mRNA, constructing an original miRNA-mRNA regulatory network in KIT/PDGFRA WT-SDH deficient GIST patients. PATIENTS & METHODS: Analyses were carried out on KIT/PDGFRA mutant versus KIT/PDGFRA WT-SDH deficient GIST. Genome-wide miRNA and gene-expression analysis were performed using Agilent Human miRNA microarray and Affimetrix array, respectively. RESULTS: Three potential regulatory networks (IGF1R → miR-139-5p/miR-455/let-7b, cyclin-dependent kinase 6 (CDK6) → miR-139-5p/let-7b and CD44 → miR-330-3p) were identified. CONCLUSION: The miR-139-5p, 455-5p and let-7b signature, in particular, may represent an important therapeutic target in KIT/PDGFRA WT-SDH deficient GIST, usually characterized by IGF1R overexpression.
20
Samuel Godár, Tan A. Ince, George W. Bell et al. · Cell · 2008 · 466 citations
Medicine, Cancer Biology, Oncology +12